论文部分内容阅读
我院于１９８５年至１９９１年，应用Ｂｕｃｈｌｅ后装治疗机￣（１３７）铯近距离放射治疗配合￣（６０）钴外照射，治疗女阴癌１５例。鳞癌１３例，腺癌２例。Ｉ期１例，Ⅱ期３例，Ⅲ期８例和Ⅳ期３例．￣（１３７）铯近距离治疗，每周一次，每次肿瘤基底剂量为５Ｇｙ，计５Ｇｙ５例占２６．１％，１０Ｇｙ２例占１３．３％，１５～２０Ｇｙ６例占４０．０％，大于２０Ｇｙ３例占２０．０％。近期疗效：ＣＲ５例占３３．３％，ＰＲ９例占６０．０％，ＣＲ＋ＰＲ１４例占９３．３％，ＮＲ１例占６．７％。随诊：放疗后一、二、三、四、五年存活率分别为７３．７％、６０．０％、３３．３％、２５．０％和２７．３％。未发现放疗并发症。
Our hospital from 1985 to 1991, the application of Buchle after-treatment machine ~ (137) cesium brachytherapy with ¯ (60) cobalt external irradiation, the treatment of female vulvar cancer in 15 cases. 13 cases of squamous cell carcinoma and 2 cases of adenocarcinoma. 1 in stage I, 3 in stage II, 8 in stage III and 3 in stage IV. ~ (137) cesium brachytherapy once a week, each tumor substrate dose of 5Gy, accounting for 5Gy 5 cases accounted for 26.1%, 10Gy 2 cases accounted for 13.3%, 15 ~ 20Gy 6 cases accounted for 40.0%, greater than 20Gy3 Cases accounted for 20.0%. Short-term efficacy: CR5 cases accounted for 33.3%, PR9 cases accounted for 60.0%, CR + PR14 cases accounted for 93.3%, NR1 cases accounted for 6.7%. Follow-up: The survival rates of one, two, three, four and five years after radiotherapy were 73.7%, 60.0%, 33.3%, 25.0% and 27.3% respectively. No radiotherapy complications were found.